New Delhi, May 27 -- India's pharmaceutical sector is witnessing a steady shift towards renewable energy adoption and stronger sustainability practices, driven largely by rising pressure from regulated export markets such as Europe and the UK, according to a study by ICRA ESG Ratings Limited.

The report said renewable energy (RE) consumption across a sample of 53 pharmaceutical companies rose from 17 per cent in FY2023 to 25 per cent in FY2025, reflecting a gradual move towards cleaner energy sources. Active Pharmaceutical Ingredients (API) manufacturers recorded the sharpest rise, with RE usage increasing from 21 per cent to 31 per cent during the period, while formulation manufacturers improved from 9 per cent to 17 per cent. Integrate...